Rajpaul Attariwala - Net Worth and Insider Trading

Rajpaul Attariwala Net Worth

The estimated net worth of Rajpaul Attariwala is at least $987 dollars as of 2024-11-13. Rajpaul Attariwala is the Director of Algernon Pharmaceuticals Inc and owns about 12,337 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $987. Details can be seen in Rajpaul Attariwala's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rajpaul Attariwala has not made any transactions after 2022-04-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rajpaul Attariwala

To

Rajpaul Attariwala Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rajpaul Attariwala owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .

Click here to see the complete history of Rajpaul Attariwala’s form 4 insider trades.

Insider Ownership Summary of Rajpaul Attariwala

Ticker Comapny Transaction Date Type of Owner
XCNQ:AGN Algernon Pharmaceuticals Inc 2022-04-12 Director

Rajpaul Attariwala Latest Holdings Summary

Rajpaul Attariwala currently owns a total of 1 stock. Rajpaul Attariwala owns 12,337 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of April 12, 2022, with a value of $987.

Latest Holdings of Rajpaul Attariwala

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XCNQ:AGN Algernon Pharmaceuticals Inc 2022-04-12 12,337 0.08 987

Holding Weightings of Rajpaul Attariwala


Rajpaul Attariwala Form 4 Trading Tracker

According to the SEC Form 4 filings, Rajpaul Attariwala has made a total of 1 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 900 shares on April 12, 2022, which cost Rajpaul Attariwala around $5,607.

Insider Trading History of Rajpaul Attariwala

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rajpaul Attariwala Trading Performance

GuruFocus tracks the stock performance after each of Rajpaul Attariwala's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajpaul Attariwala is -46.45%. GuruFocus also compares Rajpaul Attariwala's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajpaul Attariwala within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rajpaul Attariwala's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rajpaul Attariwala

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -20.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.36 LIMIT LIMIT LIMIT LIMIT LIMIT

Rajpaul Attariwala Ownership Network

Ownership Network List of Rajpaul Attariwala

No Data

Ownership Network Relation of Rajpaul Attariwala

Insider Network Chart

Rajpaul Attariwala Owned Company Details

What does Algernon Pharmaceuticals Inc do?

Who are the key executives at Algernon Pharmaceuticals Inc?

Rajpaul Attariwala is the Director of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer James Kinley .

Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary

Over the past 18 months, Rajpaul Attariwala made no insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN). Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 62,500 shares made by Christopher Moreau , a net purchase of 60,500 shares made by Christopher Scott Bryan , and a net purchase of 12,500 shares made by James Kinley .

In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 135,500 shares were bought by its insiders, resulting in a net purchase of 135,500 shares.

Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Algernon Pharmaceuticals Inc Insider Transactions

No Available Data

Rajpaul Attariwala Mailing Address

Above is the net worth, insider trading, and ownership report for Rajpaul Attariwala. Currently GuruFocus does not have mailing address information for Rajpaul Attariwala.